Plaque burden
Biomarker1 paper
Latest
34International ImmunopharmacologyAnimals
Rapamycin improves efferocytosis and reduces plaques in mice
In ApoE-/- mice, rapamycin reduced aortic lipid-positive area from 25.32 ± 0.98% to 12.28 ± 1.49% and increased plaque efferocytosis index from 0.36 ±…In ApoE-/- mice, rapamycin reduced aortic lipid-positive area from 25.32 ± 0.98% to 12.28 ± 1.49% and increased plaque efferocytosis index from 0.36 ± 0.02 to 1.37 ± 0.15.
Polish Archives of Internal MedicineHumans
Carotid plaque burden in the adult Polish urban population and its association with body fat distribution
Current Atherosclerosis ReportsReview
Non-HDL Cholesterol as a Predictor of Coronary Atherosclerosis in South Asians: A Narrative Review
Behavioural Brain ResearchAnimals
Age-related emergence of behavioral deficits and amyloid pathology in the J20 mouse model of Alzheimer's disease
Journal of Cardiovascular Development and DiseaseHumans
Clinical-Metabolic Risk Phenotypes and Carotid Plaque Burden Among Community-Dwelling Individuals at High Cardiovascular Risk: An Exploratory Cross-Sectional Study
Neurobiology of AgingHumans
Neuropathology of centenarians and supercentenarians: An autopsy study
Preprints.orgReviewPreprint